Physician profile
Francesco Tani
NPI 1851884522
$4,402.97
in general payments reported to CMS, 2019-2025
16 companies · $1,667 in 2025
The $1,667 reported for 2025 was more than what 91% of Addiction Medicine (Family Medicine) providers received nationally (typical 2025 total: $143).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $172 · 2023: $1,838 · 2024: $726 · 2025: $1,667.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,231.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,230.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $2,008.89 | 2022-2025 | Cabenuva, Dovato, Apretude |
| Gilead Sciences, INC. | $1,068.72 | 2022-2025 | Yeztugo, Biktarvy |
| Theratechnologies INC. | $371.45 | 2023-2025 | Trogarzo, Egrifta |
| Merck Sharp & Dohme LLC | $298.33 | 2023-2025 | Pifeltro, Delstrigo, Isentress |
| Emd Serono, INC. | $97.57 | 2024-2025 | |
| Indivior INC. | $97.19 | 2022-2024 | Sublocade |
| Braeburn INC. | $82.70 | 2023-2025 | Brixadi |
| Dynavax Technologies Corporation | $78.84 | 2022-2025 | Heplisav-B |
| Exact Sciences Corporation | $70.30 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Janssen Biotech, INC. | $68.41 | 2022-2023 | Symtuza |
| Axsome Therapeutics, INC. | $35.54 | 2025 | Auvelity |
| Rgh Enterprises LLC | $34.40 | 2025 | |
| Uswm, LLC | $33.90 | 2023 | Lucemyra, Zimhi |
| Organon LLC | $24.17 | 2023 | Nexplanon |
| Otsuka America Pharmaceutical, INC. | $19.15 | 2025 | Rexulti |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seqirus USA INC | $13.41 | 2024 | Fluad, Flucelvax |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Francesco Tani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.